Mar 11, 2014 at 13:57 | Source: CNBC-TV18
Pankaj Jain of Sunteck Wealthmax recommends going long in Ashok Leyland, IRB Infrastructure Developers and L&T Finance Holdings.
Mar 11, 2014 at 10:48 | Source: CNBC-TV18
Manishi Raychadhury of BNP Paribas says the investing story of India remains intact over the longer term on reasonable valuations. He names Persistent, Crompton Greaves, IRB Infra and Indusind Bank among top midcap buys.
Mar 10, 2014 at 14:05 | Source: CNBC-TV18
Pankaj Jain of Sunteck Wealthmax recommends going long in NCC and IRB Infrastructure Developers.
Feb 14, 2014 at 12:34 | Source: CNBC-TV18
Sharmila Joshi, Independent Analyst recommends selling Voltas with a target of Rs 115 and advises buying Sintex Industries with a target of Rs 33.50.
Feb 08, 2014 at 14:41 | Source: Moneycontrol.com
We sift through some of the top interviews that were published on Moneycontrol.com through the week and bring you a collection of the best quotes from market-men, business people and policymakers.
Feb 07, 2014 at 15:02 | Source: CNBC-TV18
SP Tulsian of sptulsian.com recommends going long in IRB Infrastructure Developers with a target of Rs 75 and advises shorting Punjab National Bank with a target of Rs 548.
Feb 05, 2014 at 16:58 | Source: CNBC-TV18
VD Mhaiskar, CMD, IRB Infrastracture says the company did not incur much of a loss due to vandalism as the state managed to step in at the right time.
Jan 31, 2014 at 19:36 | Source: PTI
Its total income from operations declined marginally by 4 percent in Q3, 2013-14 to Rs 877.22 crore, from Rs 913.85 in the year-ago period.
Jan 31, 2014 at 14:17 | Source: CNBC-TV18
Independent Technical Analyst, Rakesh Gandhi is of the view that one may buy Ipca Laboratories for target of Rs 844 and sell LIC Housing Finance with a target of Rs 187.1.
Jan 31, 2014 at 09:00 | Source: CNBC-TV18
Pankaj Jain of Sunteck Wealthmax advises buying Marksans Pharma for a target price of Rs 18.85 and Aurobindo Pharma for a target price of Rs 468.